In a letter to North Dakota State Sen. Judy Lee (R-ND), the Partnership to Improve Patient Care (PIPC) offered strong criticism of legislation that would deploy the discriminatory quality-adjusted-life-years (QALY) metric as a means of addressing rising health care costs.
|
On November 1, 2022, letters (option 1; option 2) with 36 signatures were provided to the Oregon Health Evidence Review Commission (HERC) related to its proposed guide for use of quality-adjusted life years (QALYs) in HERC’s meeting materials, processes and decisions, particularly related to the prioritized list of services for coverage under Medicaid.
Advocates in Oregon joined a letter to the Health Evidence Review Commission (HERC) related to their review of proposed policy options to guide the Commission's use of quality-adjusted life years (QALYs) in meeting materials and decision-making.
PIPC Joins Over 80 Organizations Urging HHS Civil Rights Office to Ban QALYs Across Federal Programs10/3/2022
PIPC joined over 80 organizations in signing a letter to the HHS Office for Civil Rights commenting on the proposed rule implementing Section 1557 of the Affordable Care Act. The groups support a comprehensive proposed rule seeking to strengthen civil rights protections in federally funded health programs and HHS programs and agreed that the ability to access needed health care fully and free from discrimination is critical and requires action to support and strengthen existing nondiscrimination laws.
In a letter to the Institute for Clinical and Economic Review (ICER), the Partnership to Improve Patient Care (PIPC) submitted comments on ICER's draft evidence report on treatments for beta thalessemia. In a letter to the Medicare Payment Advisory Commission (MedPAC), the Partnership to Improve Patient Care (PIPC) urged the commission to avoid reliance on discriminatory value assessment metrics as the basis for Medicare coverage policy. PIPC’s concerns stem from comments by MedPAC commissioners during the April 2022 public meeting where metrics of clinical and cost effectiveness were discussed, particularly the quality-adjusted-life-years (QALY) metric. |
Topics
All
Archives
February 2024
|